Methods for the treatment and prevention of renal and fatty liver disorders

摘要

The invention comprises (a) canagliflozin and (b) one or more ACE inhibitors or one or more ARBs or one or more PPARγ agonists. A method of treating, delaying, slowing the progression and / or preventing a disorder comprising administering to a subject in need thereof a therapeutically effective amount of a combination therapeutic agent consisting of or consisting essentially of, and A method for treating, delaying, slowing and / or preventing fatty liver disorders (eg, NASH or NAFLD) comprising administering to a subject in need thereof a therapeutically effective amount of canagliflozin Objective.